Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2016.08.02
关于副总经理辞职的公告
2016.07.29
关于对外投资的进展公告
2016.07.29
关于控股子公司对外融资的进展公告
2016.07.29
2016年半年度业绩快报
2016.07.15
2016年第一次临时股东大会的法律意见书
2016.07.15
2016年第一次临时股东大会决议公告
2016.07.09
金融衍生品交易业务内部控制制度（2016年7月）
2016.07.09
关于公司与花旗银行进行交叉货币掉期交易的公告
2016.07.09
第三届董事会第二十四次会议决议公告
2016.07.05
关于公司员工持股计划股票完成出售的公告
第一页
上一页
89
90
91
92
93
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
